Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 3Active not recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Genitourinary 2Breast 2Thoracic 1Gastrointestinal 1

Conditions

Breast Neoplasms 55Neoplasm Metastasis 5Triple Negative Breast Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Endometrial Neoplasms 2Colorectal Neoplasms 2Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms by Site 1Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Hormone Receptor Positive Breast Carcinoma 1Head and Neck Neoplasms 1HR-positive, HER2-negative Breast Neoplasms 1HER2-positive Metastatic Breast Cancer 1Genital Neoplasms, Female 1Genetic Diseases, Inborn 1Estrogen Receptor Positive Breast Cancer 1ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer 1Disease Progression 1

Interventions

pembrolizumab 10Cisplatin 8Radiotherapy 6Magnetic Resonance Spectroscopy 6Carboplatin 6Specimen Handling 5Paclitaxel 5Brachytherapy 5Fluorodeoxyglucose F18 4dostarlimab 3atezolizumab 3Trastuzumab 3Radiation 3Platinum 3Nivolumab 3Human Papillomavirus DNA Tests 3Docetaxel 3Colposcopy 31,2-diaminocyclohexaneplatinum II citrate 3zimberelimab 2tislelizumab 2spartalizumab 2olaparib 2human papillomavirus vaccine, L1 type 16, 18 2durvalumab 2Vaccines 2Surveys and Questionnaires 2Standard of Care 2Robotic Surgical Procedures 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Uterine Cervical Neoplasms × Fulvestrant × Clear all
NCT07038369 2026-06-03

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Atavistik Bio, Inc

Phase 1 Active not recruiting
134 enrolled
BreastGenitourinaryGynecologic

Breast Diseases, Breast Neoplasms, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Neoplasms, Prostatic Neoplasms, Urogenital Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04579380 2025-12-19

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Seagen Inc.

Phase 2 Active not recruiting
217 enrolled 19 charts
BreastGastrointestinalGenitourinaryGynecologicThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Urologic Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡